ALBERT

Description: To date, changes in functional performance have been systematically studied after short-duration space flight. As important as the postflight functional changes have been, full functional recovery has never been investigated or established for long-duration flights. The Pilot Field Test (PFT) experiment, conducted with participation of ISS crewmembers traveling on Soyuz expeditions 34S - 41S, is comprised of several tasks designed to study the recovery of sensorimotor abilities of astronauts during the first 24 hours after landing and beyond. The objective of the Seat Egress - Walk and Obstacle Test, developed by NASA's Russian collaborators at the Institute for Biomedical Problems, is to address this gap in knowledge. This will allow us to characterize the ability of crewmembers to perform critical mission requirements that they will be expected to perform after an unassisted landing following 6 to 12 months in microgravity.

Description: The Launch and Entry Suit (LES) has been worn by astronauts since 1988 for Space Shuttle launch and landing. Previous work indicated that carbon dioxide (CO2) accumulation in the LES non-conformal helmet might be high during locomotion while wearing the LES. The purpose of this study was to characterize the inspired CO2%, metabolic requirements, and egress performance during a simulation of an unaided egress from the Space Shuttle in healthy male subjects wearing the LES and walking on a treadmill. With the helmet visor closed, 12 male subjects completed a 6-min seated prebreathe with 100% O2 followed by a 2-min stand and 5 min of walking at 1.56 m/sec (5.6 km/h, 3.5 mph) as a simulation of unaided egress. All subjects walked with four different G-suit pressures (0.0, 0.5, 1.0, 1.5 psi). After a 10-min recovery, subjects walked 5 min with the same G-suit pressure and helmet visor open for the measurement of metabolic rate (VO2). When G-suit inflation levels were 1.0 or 1.5 psi, only 4 of our 12 healthy, non-micro-gravity exposed subjects completed the unaided egress. Inspired CO2 levels greater than 4% were routinely observed during walking. The metabolic cost at the 1.5 psi G-suit inflation was over 135% of the metabolic cost at 0.0 psi inflation. During unaided egress, G-suit inflation pressures of 1.0 (required inflation for missions greater than 11 days) and 1.5 psi resulted in elevated CO2 in the LES helmet and increased metabolic cost of walking, either of which could impact unaided egress by returning space flight crews.

Description: Musculoskeletal, cardiovascular, and sensorimotor deconditioning have been observed consistently in astronauts and cosmonauts following long-duration spaceflight. Studies in bed rest, a spaceflight analog, have shown that high intensity resistive or aerobic exercise attenuates or prevents musculoskeletal and cardiovascular deconditioning, respectively, but complete protection has not been achieved during spaceflight. Exercise countermeasure hardware used during earlier International Space Station (ISS) missions included a cycle ergometer, a treadmill, and the interim resistive exercise device (iRED). Effectiveness of the countermeasures may have been diminished by limited loading characteristics of the iRED as well as speed restrictions and subject harness discomfort during treadmill exercise. The Advanced Resistive Exercise Device (ARED) and the second generation treadmill were designed to address many of the limitations of their predecessors, and anecdotal reports from ISS crews suggest that their conditioning is better preserved since the new hardware was delivered in 2009. However, several countermeasure devices to protect different physiologic systems will not be practical during exploration missions when the available volume and mass will be severely restricted. The combined countermeasure device (CCD) integrates a suite of hardware into one device intended to prevent spaceflight-induced musculoskeletal, cardiovascular, and sensorimotor deconditioning. The CCD includes pneumatic loading devices with attached cables for resistive exercise, a cycle for aerobic exercise, and a 6 degree of freedom motion platform for balance training. In a proof of concept test, ambulatory untrained subjects increased muscle strength (58%) as well as aerobic capacity (26%) after 12-weeks of exercise training with the CCD (without balance training), improvements comparable to those observed with traditional exercise training. These preliminary results suggest that this CCD can concurrently improve musculoskeletal and cardiovascular conditioning in ambulatory subjects, but further work is required to validate its use as countermeasure to spaceflight-induced deconditioning.